Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
It must also be considered whether these medications are delivered consistently over the entire duration of a trial, or whether they are given to achieve a certain weight loss, and then a maintenance intervention is used to aim to keep this weight off
Precautions Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle
However, doing it too quickly may lead to the development of the keto diet rash (*)
Typical PA requirements include: Confirmed diagnosis of type 2 diabetes or obesity Documented BMI (often 30 or 27 with comorbidities) Failed trials of other medications Lifestyle modification attempts Recent A1C lab values (for diabetes) Documentation Must Include Height and weight with calculated BMI Diagnosis supporting medical necessity Treatment plan Follow-up and monitoring plan Compliance & Audit Risk GLP-1 medications are a high-risk audit target due to: Rapid growth in utilization High drug cost Off-label prescribing Weight-loss demand Common audit issues: Incorrect diagnosis codes Missing BMI documentation Lack of medical necessity Billing weight-loss drugs to Medicare Inappropriate use of unclassified J-codes Medicare Coverage Rules Medicare Part D generally does not cover weight-loss drugs , even if FDA-approved for obesity
US$ 25.33
US$ 27.81
US$ 21.60
